The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Basgoz Nesli since 2007.
The trader's CIK number is 1361580.
At the time of the last reporting, Basgoz Nesli was the Director of Allergan Plc. (stock ticker symbol AGN).
Also see all insider trading activities at Allergan Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | AGN | 0 | $0 | 1,055 | $200,502 | 1,889 | $153,311 |
| 2017 | AGN | 0 | $0 | 1,889 | $416,430 | 1,889 | $159,507 |
| 2016 | AGN | 0 | $0 | 1,717 | $389,469 | 2,348 | $222,285 |
| 2015 | AGN | 0 | $0 | 4,500 | $1,375,166 | 4,500 | $371,385 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | FRX | 0 | $0 | 12,200 | $457,097 | 9,621 | $262,027 |
| 2010 | FRX | 0 | $0 | 1,000 | $28,456 | 0 | $0 |
| 2007 | FRX | 0 | $0 | 3,500 | $180,670 | 3,500 | $136,412 |
2. Forest Laboratories Inc (FRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-08-30 | AGN | Sale | 1,055 | 190.05 | 200,502 |
| 2018-08-10 | AGN | Option Ex | 1,889 | 81.16 | 153,311 |
| 2017-05-18 | AGN | Option Ex | 1,889 | 84.44 | 159,507 |
| 2017-05-18 | AGN | Sale | 1,889 | 220.45 | 416,430 |
| 2016-12-08 | AGN | Sale | 500 | 188.72 | 94,360 |
| 2016-08-05 | AGN | Option Ex | 1,889 | 97.62 | 184,404 |
| 2016-08-05 | AGN | Sale | 758 | 253.02 | 191,789 |
| 2016-05-11 | AGN | Option Ex | 459 | 82.53 | 37,881 |
| 2016-05-11 | AGN | Sale | 459 | 225.10 | 103,320 |
| 2015-12-07 | AGN | Option Ex | 2,300 | 82.53 | 189,819 |
| 2015-12-07 | AGN | Sale | 2,300 | 312.96 | 719,808 |
| 2015-06-09 | ACT | Option Ex | 2,200 | 82.53 | 181,566 |
| 2015-06-09 | ACT | Sale | 2,200 | 297.89 | 655,358 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-07 | FRX | Sale | 12,200 | 37.47 | 457,097 |
| 2013-03-07 | FRX | Option Ex | 9,621 | 27.23 | 262,027 |
| 2010-07-22 | FRX | Sale | 1,000 | 28.46 | 28,456 |
| 2007-03-07 | FRX | Option Ex | 3,500 | 38.98 | 136,412 |
| 2007-03-07 | FRX | Sale | 3,500 | 51.62 | 180,670 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Basgoz Nesli (Director of Allergan Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.